A. Grein
Impact in
- Pharmacology top 2%
- Microbial Natural Products and Biosynthesis
- Toxicology top 2%
- Bioactive Compounds and Antitumor Agents
Papers in
- Pharmacology 23
- Microbial Natural Products and Biosynthesis 23
-
- Microbial Metabolism and Applications 3
- Co-authors
- Celestino Spalla (15 shared papers)Giuseppe Cassinelli (8 shared papers)Federico Arcamone (6 shared papers)PIERGIUSEPPE OREZZI (3 shared papers)Samuel P. Meyers (1 shared paper)Anna Maria Casazza (3 shared papers)AURORA SANFILIPPO (1 shared paper)Aurelio Di Marco (2 shared papers)
- Journals
- The Journal of Antibiotics (5 papers)Archives of Microbiology (4 papers)Cellular and Molecular Life Sciences (2 papers)Biotechnology and Bioengineering (2 papers)Die Naturwissenschaften (1 paper)
- Partner nations
- ItalyUnited States
In The Last Decade
A. Grein
22 papers receiving 817 citations
A. Grein's Hit Papers
Peers
Comparison fields: 5 of 83
- Pharmacology 422
- Toxicology 90
- Microbiology 15
- Biotechnology 45
- Cardiology and Cardiovascular Medicine 126
Countries citing papers authored by A. Grein
This map shows the geographic impact of A. Grein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Grein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Grein more than expected).
Fields of papers citing papers by A. Grein
This network shows the impact of papers produced by A. Grein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Grein. The network helps show where A. Grein may publish in the future.
Co-authors
The 24 scholars most cited alongside A. Grein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Adriamycin, 14‐hydroxydaimomycin, a new antitumor antibiotic from S. Peucetius var. caesius Hit paper breakdown → | 1969 | 529 |
| 2 | 1958 | 62 | |
| 3 | 2000 | 58 | |
| 4 | 1967 | 38 | |
| 5 | 1954 | 37 | |
| 6 | 1987 | 37 | |
| 7 | 1982 | 36 | |
| 8 | 1978 | 30 | |
| 9 | 1969 | 26 | |
| 10 | 1989 | 20 | |
| 11 | 1970 | 16 | |
| 12 | 1985 | 15 | |
| 13 | 1978 | 13 | |
| 14 | 1974 | 12 | |
| 15 | 1982 | 12 | |
| 16 | 1980 | 11 | |
| 17 | 1981 | 11 | |
| 18 | 1990 | 6 | |
| 19 | 1955 | 5 | |
| 20 | 1965 | 5 |
About A. Grein
A. Grein is a scholar working on Pharmacology, Biotechnology, Microbiology, Clinical Biochemistry and Toxicology, having authored 24 papers that have together received 990 indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (23 papers), Microbial Metabolism and Applications (3 papers), Actinomycetales infections and treatment (2 papers), Bioactive Compounds and Antitumor Agents (1 paper), Porphyrin Metabolism and Disorders (1 paper), Bacterial Identification and Susceptibility Testing (1 paper) and Cyclization and Aryne Chemistry (1 paper). The work is most often cited by research in Pharmacology (422 citations), Toxicology (90 citations), Microbiology (15 citations), Biotechnology (45 citations) and Cardiology and Cardiovascular Medicine (126 citations). A. Grein has collaborated with scholars based in Italy and United States. Frequent co-authors include Celestino Spalla, Giuseppe Cassinelli, Federico Arcamone, PIERGIUSEPPE OREZZI, Samuel P. Meyers, Anna Maria Casazza, AURORA SANFILIPPO, Aurelio Di Marco, Graziella Pratesi and Anacleto Minghetti. Their work appears in journals such as The Journal of Antibiotics, Archives of Microbiology, Cellular and Molecular Life Sciences, Biotechnology and Bioengineering and Die Naturwissenschaften.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.